Literature DB >> 23419346

Hepatitis C virus infections in the Democratic Republic of Congo exhibit a cohort effect.

James C Iles1, G L Abby Harrison, Sinead Lyons, Cyrille F Djoko, Ubald Tamoufe, Matthew Lebreton, Bradley S Schneider, Joseph N Fair, Felix M Tshala, Patrick K Kayembe, Jean Jacques Muyembe, Samuel Edidi-Basepeo, Nathan D Wolfe, Paul Klenerman, Peter Simmonds, Oliver G Pybus.   

Abstract

The prevalence and genetic diversity of hepatitis C virus (HCV) and human pegivirus (HPgV) in many regions of sub-Saharan Africa is poorly characterized, including in the Democratic Republic of Congo--the largest country in the region and one of the most populous. To address this situation we conducted a molecular epidemiological survey of HCV and HPgV (previously named GB Virus C or hepatitis G virus) in samples collected in 2007 from 299 males from the DRC, whose ages ranged from 21 to 71 years old. Samples were tested for the presence of HCV antibodies by ELISA and reactive samples were subsequently tested for HCV RNA using RT-PCR in which both the HCV Core and NS5B genome regions were amplified. Remaining samples were tested for HPgV RNA and the HPgV NS3 genome region of positive samples was amplified. For HCV, 13.7% of the samples were seropositive (41/299) but only 3.7% were viremic (11/299). HPgV RNA was found in 12.7% (33/259) of samples. HCV viremia was strongly associated with age; the percentage of samples that contained detectable HCV RNA was ~0.5% in those younger than 50 and 13% in those older than 50. Our study represents the first systematic survey of HCV genetic diversity in the DRC. HCV sequences obtained belonged to diverse lineages of genotype 4, including subtypes 4c, 4 k, 4 l and 4r, plus one unclassified lineage that may constitute a new subtype. These data suggest that HCV in the DRC exhibits an age 'cohort effect', as has been recently reported in neighbouring countries, and are consistent with the hypothesis that HCV transmission rates were higher in the mid-twentieth century, possibly as a result of parenteral, iatrogenic, or other unidentified factors. Different HCV subtypes were associated with individuals of different ages, implying that HCV infection in the DRC may have arisen through multiple separate HCV epidemics with different causes.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Democratic Republic of Congo; Hepatitis C; Human pegivirus; Phylogeny; Prevalence; RNA

Mesh:

Substances:

Year:  2013        PMID: 23419346     DOI: 10.1016/j.meegid.2013.01.021

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  15 in total

1.  An Efficient, Large-Scale Survey of Hepatitis C Viremia in the Democratic Republic of the Congo Using Dried Blood Spots.

Authors:  Jonathan B Parr; Evans K Lodge; Vera Holzmayer; Jacques Pepin; Eric H Frost; Michael W Fried; David R McGivern; Stanley M Lemon; Corinna Keeler; Michael Emch; Kashamuka Mwandagalirwa; Antoinette Tshefu; Franck Fwamba; Jérémie Muwonga; Steven R Meshnick; Gavin Cloherty
Journal:  Clin Infect Dis       Date:  2018-01-06       Impact factor: 9.079

2.  HIV epidemiology. The early spread and epidemic ignition of HIV-1 in human populations.

Authors:  Nuno R Faria; Andrew Rambaut; Marc A Suchard; Guy Baele; Trevor Bedford; Melissa J Ward; Andrew J Tatem; João D Sousa; Nimalan Arinaminpathy; Jacques Pépin; David Posada; Martine Peeters; Oliver G Pybus; Philippe Lemey
Journal:  Science       Date:  2014-10-02       Impact factor: 47.728

3.  Prevalence of hepatitis B virus infection among health care workers in a tertiary hospital in Tanzania.

Authors:  A Mueller; L Stoetter; S Kalluvya; A Stich; C Majinge; B Weissbrich; C Kasang
Journal:  BMC Infect Dis       Date:  2015-09-23       Impact factor: 3.090

4.  The Impact of Human Pegivirus on CD4 Cell Count in HIV-Positive Persons in Botswana.

Authors:  Kombo F N'Guessan; Motswedi Anderson; Bonolo Phinius; Sikhulile Moyo; Alyyah Malick; Tshepiso Mbangiwa; Wonderful T Choga; Joseph Makhema; Richard Marlink; Max Essex; Rosemary Musonda; Simani Gaseitsiwe; Jason T Blackard
Journal:  Open Forum Infect Dis       Date:  2017-10-10       Impact factor: 3.835

5.  Phylogeography and epidemic history of hepatitis C virus genotype 4 in Africa.

Authors:  James C Iles; Jayna Raghwani; G L Abby Harrison; Jacques Pepin; Cyrille F Djoko; Ubald Tamoufe; Matthew LeBreton; Bradley S Schneider; Joseph N Fair; Felix M Tshala; Patrick K Kayembe; Jean Jacques Muyembe; Samuel Edidi-Basepeo; Nathan D Wolfe; Peter Simmonds; Paul Klenerman; Oliver G Pybus
Journal:  Virology       Date:  2014-08-06       Impact factor: 3.616

6.  Evaluation of Viremia Frequencies of a Novel Human Pegivirus by Using Bioinformatic Screening and PCR.

Authors:  David Bonsall; William F Gregory; Camilla L C Ip; Sharyne Donfield; James Iles; M Azim Ansari; Paolo Piazza; Amy Trebes; Anthony Brown; John Frater; Oliver G Pybus; Phillip Goulder; Paul Klenerman; Rory Bowden; Edward D Gomperts; Eleanor Barnes; Amit Kapoor; Colin P Sharp; Peter Simmonds
Journal:  Emerg Infect Dis       Date:  2016-04       Impact factor: 6.883

Review 7.  Epidemiology of viral hepatitis in the Republic of Congo: review.

Authors:  Laure Stella Ghoma Linguissi; Celine Nguefeu Nkenfou
Journal:  BMC Res Notes       Date:  2017-12-02

Review 8.  Aspects on the history of transmission and favor of distribution of viruses by iatrogenic action: perhaps an example of a paradigm of the worldwide spread of HIV.

Authors:  Lutz G Gürtler; Josef Eberle
Journal:  Med Microbiol Immunol       Date:  2017-04-22       Impact factor: 3.402

9.  Co-infection of Schistosoma mansoni/hepatitis C virus and their associated factors among adult individuals living in fishing villages, north-western Tanzania.

Authors:  Humphrey D Mazigo; Stella Kepha; Godfrey M Kaatano; Safari M Kinung'hi
Journal:  BMC Infect Dis       Date:  2017-10-10       Impact factor: 3.090

10.  Low prevalence of HCV infection with predominance of genotype 4 among HIV patients living in Libreville, Gabon.

Authors:  Angélique Ndjoyi-Mbiguino; Arnaud John Kombe Kombe; Berthold Bivigou-Mboumba; Samira Zoa-Assoumou; Falone Larissa Akombi; Francis Nzengui Nzengui; Hervé M'boyis Kamdem; Sandrine François-Souquière
Journal:  PLoS One       Date:  2018-01-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.